Stereotactic Body Radiation Therapy and Short-Term Androgen Ablation for Intermediate-Risk, Localized, Adenocarcinoma of the Prostate.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antiandrogens
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 28 May 2021 Biomarkers information updated
- 05 Jul 2013 Primary endpoint amended and planned number of patients changed from 103 to 105 as reported by ClinicalTrials.gov.
- 01 May 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.